Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department's is taking to ensure the adequate supply of unlicensed medicines for use in clinical trials in the event that the UK leaves the EU without a deal.

The Government has issued guidance on preparations to ensure continuity of supply of licensed medicines in the unlikely event of a no-deal. We recognise fully the importance of Investigational Medicinal Products supply and are planning communications to those organisations running clinical trials – life science industries trade associations and member companies, umbrella organisations for research charities and university hospitals, and more widely.